GMO biosafety research in China.

نویسندگان

  • Shirong Jia
  • Yufa Peng
چکیده

Over the years, genetically modified organism (GMO) development and regulation in China have regularly attracted international attention. In the early 1990s, China became the first country to commercialize a genetically modified (GM) crop with planting of a virus-resistant transgenic tobacco variety on a relatively large scale, while other parts of the world were debating about the risks of GMOs. A few years later, the GM tobacco was removed from cultivation because of strong pressure from outside of the country. This situation was not changed until late 1997, when an insect-resistant cotton variety was approved by the GMO Biosafety Committee in the Ministry of Agriculture for commercial cultivation in five provinces. This paper will give an overview of GMO development and biosafety research in China.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Negative and positive data, statistical power, and confidence intervals.

What is negative about negative data? Scientists understand negative data from our training in data analysis and statistics, where we use a positive concept of negative data. Negative data are data that do not enable us to reject our null hypothesis. Such data are often difficult to publish because it is not possible to prove the null hypothesis. Every active research scientist has a large draw...

متن کامل

How well is Environmental Biosafety Research supporting the scientific debate on the biosafety of genetically modified organisms (GMOs)?

One of the most direct routes to informing scientific debates is through the timely publication of relevant research results. By making a comparison of the number and type of articles published by Environmental Biosafety Research (EBR) with those from other journals active in the arena of GMO biosafety, it is possible to shed light on the answer to the question posed in the title. To do this, w...

متن کامل

Genetic modification through oligonucleotide-mediated mutagenesis. A GMO regulatory challenge?

In the European Union, the definition of a GMO is technology-based. This means that a novel organism will be regulated under the GMO regulatory framework only if it has been developed with the use of defined techniques. This approach is now challenged with the emergence of new techniques. In this paper, we describe regulatory and safety issues associated with the use of oligonucleotide-mediated...

متن کامل

Identification of potentially hazardous human gene products in GMO risk assessment.

Genetically modified organisms (GMOs), e.g. viral vectors, could threaten the environment if by their release they spread hazardous gene products. Even in contained use, to prevent adverse consequences, viral vectors carrying genes from mammals or humans should be especially scrutinized as to whether gene products that they synthesize could be hazardous in their new context. Examples of such po...

متن کامل

General Considerations on the Biosafety of Virus-derived Vectors Used in Gene Therapy and Vaccination

This introductory paper gathers general considerations on the biosafety of virus-derived vectors that are used in human gene therapy and/or vaccination. The importance to assess the potential risks for human health and the environment related to the use of genetically modified organisms (GMO) in this case genetically modified viral vectors is highlighted by several examples. This environmental ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Environmental biosafety research

دوره 1 1  شماره 

صفحات  -

تاریخ انتشار 2002